Search Results

You are looking at 81 - 90 of 96 items for :

  • Medical and Health Sciences x
  • Refine by Access: All Content x
Clear All

Introduction In the past decade, novel psychoactive substances (NPSs) gained a significant role on the contemporary drug scene. With a decreasing purity and availability of 3,4-methyl​enedioxy​methamphetamine (MDMA), cocaine

Open access

MDMA, which makes sense given that components include elemicin, eugenol, and safrole ( Nowak, Woźniakiewicz, Gładysz, Sowa, & Kościelniak, 2016 ). All of these are related to MDMA, and are found in the Holy Ointment. Furthermore, potent

Open access
Journal of Psychedelic Studies
Authors:
Kelley C. O’Donnell
,
Sarah E. Mennenga
, and
Michael P. Bogenschutz

participants with any use of psychedelics (including psilocybin, MDMA, LSD, mescaline, DMT, and other similar hallucinogenic compounds) within the last year at a minimum. Excluding use for the past 5 years may be appropriate for some study designs. However

Open access

Use of MDMA, family history of gambling, brother PG, and facial disfigurement None reported Abstinence 27 3 Evening tiredness None during treatment period

Open access

-DMT). Serotonergic hallucinogens are a subgroup of three classes of compounds: tryptamines, ergolines, and phenethylamines, of which the latter group also includes the so-called entactogens/empathogens (MDMA or 2C-B). In a broader context, the hallucinogen class

Open access
Journal of Psychedelic Studies
Authors:
Federico Cavanna
,
Carla Pallavicini
,
Virginia Milano
,
Juan Cuiule
,
Rocco Di Tella
,
Pablo González
, and
Enzo Tagliazucchi

, alcohol, tobacco, and cannabis) were linked to higher scores of dimensions linked to mental health impairment, and lower scores of dimensions linked to well-being and resilience. Within this last group of non-psychedelic drugs, MDMA showed different

Open access

hallucinogens: eight participants. – Psilocybin: (“magic mushrooms”) ranging from one trial to monthly use, and from 1-year use up to 10 years; – LSD: ranging from one trial to monthly use, and from 1-year use up to 10 years; – MDMA (Ecstasy): ranging from one

Open access

is a member of a closed ayahuasca Facebook group, approximately between 22 and 67 years old and holds a rather high education degree and might be preexperienced in psychedelics such as psilocybin (“magic mushrooms”), MDMA (“ecstasy”), cannabis, and

Open access
Journal of Psychedelic Studies
Authors:
Avery Sapoznikow
,
Zachary Walsh
,
Kenneth W. Tupper
,
Earth Erowid
, and
Fire Erowid

. S. , & Brewerton , T. D. ( 2016 ). Novel psychopharmacological therapies for psychiatric disorders: Psilocybin and MDMA . The Lancet Psychiatry, 3 ( 5 ), 481 – 488 . doi: 10.1016/S2215-0366(15)00576-3 10.1016/S2215

Open access

among MDMA and other drug users . Drug and Alcohol Dependence , 96 ( 1–2 ), 99 – 110 . 10.1016/j.drugalcdep.2008.02.003 Han , X. , Wu , X. , Wang , Y. , Sun , Y. , Ding , W. , Cao , M. , ( 2018 ). Alterations of resting-state static and

Open access